You are here: Industry Insights > GlaxoSmithKline

News List

Novartis brings in GlaxoSmithKline's Richard Saynor to lead turnaround of Sandoz unit firstwordpharma
April 25, 2019
Novartis announced Wednesday alongside its first-quarter financial results, that Richard Saynor, the current senior vice president of classic and established products ...
AstraZeneca's Fasenra keeps the heat on GSK's Nucala with new phase 2 data fiercepharma
April 10, 2019
AstraZeneca’s Fasenra is already pressuring GlaxoSmithKline's Nucala in severe eosinophilic asthma, and new data could help set up a showdown between the two in another indication.
Early-stage trial shows positive results for GlaxoSmithKline's PD-1 inhibitor dostarlimab in certain patients with endometrial cancer firstwordpharma
March 20, 2019
GlaxoSmithKline's Tesaro unit on Tuesday announced preliminary results from the Phase I/II GARNET study...
GlaxoSmithKline Chairman Philip Hampton bows out as company preps for split-up fiercepharma
January 22, 2019
Chairman Philip Hampton, who joined GlaxoSmithKline after its Novartis asset swap upped the ante in consumer health, is now stepping down as the British drugmaker prepares to split up the business.
Why GlaxoSmithKline and Pfizer are spinning out their consumer health business firstwordpharma
January 21, 2019
GlaxoSmithKline and Pfizer are among the drugmakers that are seeking to offload non-core units in an effort to increase focus, Business Insider reported Friday.
GlaxoSmithKline starts search for new chairman as Philip Hampton to depart firstwordpharma
January 21, 2019
GlaxoSmithKline said Monday that chairman Philip Hampton plans to step down from his position and the process to find a successor has been initiated. Hampton joined the drugmaker's board at the start of 2015, becoming chairman later that year.
GlaxoSmithKline Extends Tender Offer for TESARO, Inc. firstwordpharma
January 16, 2019
The completion of the tender offer is conditioned upon the tender by TESARO stockholders of at least one Share more than 50% of the issued and outstanding Shares.
GlaxoSmithKline, Incyte, Novo Nordisk SHARE pharmaceutical-technology
December 24, 2018
GlaxoSmithKline (GSK) and Pfizer have agreed to combine their consumer healthcare businesses with combined annual sales of £9.8bn ($12.7bn) and establish a joint venture (JV).....
GlaxoSmithKline, Pfizer to Form New Consumer Healthcare Joint Venture americanpharmaceuticalreview
December 21, 2018
GlaxoSmithKline has reached agreement with Pfizer to combine their consumer health businesses into a new Joint Venture, with combined sales of approximately $12.7 billion.....
GSK, Pfizer go for radical makeovers with giant consumer combo destined for spinoff fiercepharma
December 20, 2018
Turns out, after GlaxoSmithKline walked away from a chance to scoop up Pfizer’s consumer health business in March, it got another opportunity to team up on a deal.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page